Ayaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, Miki Katoh. Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma. // Drug Metabolism and Pharmacokinetics. – 2026. – DOI: 10.1016/j.dmpk.2026.101542. – URL: https://doi.org/10.1016/j.dmpk.2026.101542
Ayaka Kojima, Masayuki Nadai, Hiroshi Yamazaki, & Miki Katoh (2026). Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma. Drug Metabolism and Pharmacokinetics. https://doi.org/10.1016/j.dmpk.2026.101542
Ayaka Kojima, et al. “Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma.” Drug Metabolism and Pharmacokinetics, 2026. doi:10.1016/j.dmpk.2026.101542.
@article{Kojima2026,
title = {Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma},
author = {Kojima, Ayaka and Nadai, Masayuki and Yamazaki, Hiroshi and Katoh, Miki},
journal = {Drug Metabolism and Pharmacokinetics},
year = {2026},
doi = {10.1016/j.dmpk.2026.101542},
url = {https://doi.org/10.1016/j.dmpk.2026.101542}
}